ArticleTheranostics2019
Radiomic features from PSMA PET for non-invasive intraprostatic tumor discrimination and characterization in patients with intermediate- and high-risk prostate cancer - a comparison study with histology reference.
Open access · goldAbstract readEvaluation Study
In one paragraph
Article in Theranostics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers, 4 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed, 4 pooled it
15.5field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
90 citing papers in PubMed, 4 syntheses or guidelines pooled it, 141 citations in OpenAlex.
- Application of radiomics-based prediction model to predict preoperative lymph node metastasis in prostate cancer: a systematic review and meta-analysis.Frontiers in oncology · 2025Pooled it
- Joint EANM/SNMMI guideline on radiomics in nuclear medicine : Jointly supported by the EANM Physics Committee and the SNMMI Physics, Instrumentation and Data Sciences Council.European journal of nuclear medicine and molecular imaging · 2023Guideline
- Radiomics and artificial intelligence in prostate cancer: new tools for molecular hybrid imaging and theragnostics.European radiology experimental · 2022Pooled it
- Radiomics in prostate cancer imaging for a personalized treatment approach - current aspects of methodology and a systematic review on validated studies.Theranostics · 2021Pooled it
- [18F]F-DCFPyL PET/MRI radiomics for intraprostatic prostate cancer detection and metastases prediction using whole-gland segmentation.The British journal of radiology · 2025Trial
- Prognostic value of SPECT myocardial perfusion entropy in high-risk type 2 diabetic patients.European journal of nuclear medicine and molecular imaging · 2021Trial
- Article
- An interpretableEuropean journal of nuclear medicine and molecular imaging · 2026Article
- Radiomics-Based Characterization of Aggressive Prostate Cancer Variants: Diagnostic Challenges and Opportunities.Cancers · 2026Review
- PSMA PET/CT improves precision diagnosis, treatment, and clinical decision-making in prostate cancer.American journal of translational research · 2026Review
- Machine learning-based construction and validation of an radiomics model for predicting ISUP grading in prostate cancer: a multicenter radiomics study based on [68Ga]Ga-PSMA PET/CT.European journal of nuclear medicine and molecular imaging · 2025Article
- Review
- The Role of Radiomics and Artificial Intelligence Applied to Staging PSMA PET in Assessing Prostate Cancer Aggressiveness.Journal of clinical medicine · 2025Review
- Can PSMA PET detect intratumour heterogeneity in histological PSMA expression of primary prostate cancer? Analysis of [European journal of nuclear medicine and molecular imaging · 2025Article
- Bone metastases from endocrine cancer: advances in diagnosis, treatment, and prevention.Frontiers in endocrinology · 2025Review
- The Challenge of External Generalisability: Insights from the Bicentric Validation of a [Cancers · 2024Article
- Prostate-Specific Membrane Antigen-Positron Emission Tomography-Guided Radiomics and Machine Learning in Prostate Carcinoma.Cancers · 2024Review
- Interpretable multiphasic CT-based radiomic analysis for preoperatively differentiating benign and malignant solid renal tumors: a multicenter study.Abdominal radiology (New York) · 2024Article
- Prostate-Specific Membrane Antigen Expression in Patients with Primary Prostate Cancer: Diagnostic and Prognostic Value in Positron Emission Tomography-Prostate-Specific Membrane Antigen.Current oncology (Toronto, Ont.) · 2024Review
- [Cancer imaging : the official publication of the International Cancer Imaging Society · 2024Article
30 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors at 4 institutions in 1 country.
Constantinos ZamboglouDepartment of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine. University of Freiburg, Germany.
Montserrat CarlesDivision of Medical Physics, Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine. University of Freiburg, Germany.
Tobias FechterDivision of Medical Physics, Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine. University of Freiburg, Germany.
Selina KieferInstitute for Surgical Pathology, Medical Center - University of Freiburg, Faculty of Medicine. University of Freiburg, Germany.
Kathrin ReichelDepartment of Urology, Medical Center - University of Freiburg, Faculty of Medicine. University of Freiburg, Germany.
Thomas F FassbenderDepartment of Nuclear Medicine, Medical Center - University of Freiburg, Faculty of Medicine. University of Freiburg, Germany.
Peter BronsertInstitute for Surgical Pathology, Medical Center - University of Freiburg, Faculty of Medicine. University of Freiburg, Germany.
Goeran KoeberInstitute of Medical Biometry and Statistics, Medical Center-University of Freiburg, Faculty of Medicine. University of Freiburg, Germany.
Oliver SchillingInstitute for Surgical Pathology, Medical Center - University of Freiburg, Faculty of Medicine. University of Freiburg, Germany.
Juri RufDepartment of Nuclear Medicine, Medical Center - University of Freiburg, Faculty of Medicine. University of Freiburg, Germany.
Martin WernerInstitute for Surgical Pathology, Medical Center - University of Freiburg, Faculty of Medicine. University of Freiburg, Germany.
Cordula A JilgDepartment of Urology, Medical Center - University of Freiburg, Faculty of Medicine. University of Freiburg, Germany.
Dimos BaltasDivision of Medical Physics, Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine. University of Freiburg, Germany.
Michael MixDepartment of Nuclear Medicine, Medical Center - University of Freiburg, Faculty of Medicine. University of Freiburg, Germany.
Anca L GrosuDepartment of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine. University of Freiburg, Germany.
University of Freiburg · DEDeutschen Konsortium für Translationale Krebsforschung · DEUniversity Medical Center Freiburg · DEGerman Cancer Research Center · DE
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Antigens, SurfaceGlutamate Carboxypeptidase IIHistocytochemistryHumansMaleNeoplasm GradingPositron-Emission TomographyProspective StudiesProstatic NeoplasmsROC CurveSentinel Lymph NodeAntigens, SurfaceFOLH1 protein, humanGlutamate Carboxypeptidase II
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.